Bradley Sadler, MD
Psychiatry · Mobile, ALNPI 1306983143
Payments from drug & device makers
Across 637 payments — averaging $194.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$60K
- Johnson & Johnson$44K
- Supernus Pharmaceuticals, Inc.$12K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Neuronetics, Inc.$558
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 88 | $60,023 |
| Johnson & Johnson | 152 | $44,372 |
| Supernus Pharmaceuticals, Inc. | 32 | $11,557 |
| AbbVie(2 entities) | 147 | $1,770 |
| Teva Pharmaceuticals USA, Inc. | 45 | $1,643 |
| Neuronetics, Inc. | 6 | $558 |
| Takeda Pharmaceuticals U.S.A., Inc. | 34 | $546 |
| Sunovion Pharmaceuticals Inc. | 1 | $420 |
| Otsuka America Pharmaceutical, Inc. | 24 | $412 |
| Neurocrine Biosciences, Inc. | 11 | $372 |
| Lundbeck LLC | 17 | $329 |
| Alkermes, Inc. | 13 | $307 |
| Axsome Therapeutics, Inc. | 11 | $244 |
| Neos Therapeutics, LP | 12 | $232 |
| Vanda Pharmaceuticals Inc. | 7 | $199 |
| Indivior Inc. | 6 | $134 |
| Corium, LLC | 7 | $134 |
| Shire North American Group Inc | 5 | $87 |
| Eisai Inc. | 3 | $56 |
| Ironshore Pharmaceuticals Inc. | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Almatica Pharma LLC | 2 | $38 |
| Bioxcel Therapeutics, Inc. | 2 | $32 |
| Bausch Health US, LLC | 2 | $32 |
| Tris Pharma Inc | 1 | $23 |
| Orexo US, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $12 |
How this compares
$123,674 in reported general payments places this provider in the 95th percentile of 400 psychiatry providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Mobile
- Mark HaygoodMobile$348K
- Michael MarshallMobile$59K
- Mary Cohen ColsonMobile$10K
- Lucas BooneMobile$10K
- Bradley BrooksMobile$6K
- Sandra ParkerMobile$5K
- Matthew MacalusoBirmingham$2.8M
- Richard SheltonBirmingham$2.4M
- Michael FalolaTrussville$2.2M
- Armand SchachterBirmingham$758K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.